Analyst Coverage

Firm	Analyst
BTIG	Kaveri Pohlman
Cowen	Yaron Werber
HC Wainwright	Robert Burns
Jefferies	Michael Yee
RBC Capital Markets	Gregory Renza
Wedbush Securities	David Nierengarten

Contact Us

Kevin Murphy

617-340-9099
Send Email

Quick Links

SEC Filings
Investor FAQs
Events & Presentations

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Nuvation Bio Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Nuvation Bio Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address *

Investor Alert Options *

News
Events & Presentations
Quarterly Reports
Annual Reports
SEC Filings
End of Day Stock Quote

Unsubscribe

Email Alert Sign Up Confirmation

Nuvation Bio is a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates.

About us

Board of Directors
Management Team
Pipeline
Careers
Contact

General Inquiries

info@nuvationbio.com

Media or Investor Inquiries

IR@nuvationbio.com